| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2024-03-25 | Redmile Group, LLC | FATE THERAPEUTICS INC | 17,619,095 | 14.9% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | FATE THERAPEUTICS INC | 9,293,363 | 9.4% | EDGAR |
| SC 13G | 2024-02-12 | Boxer Capital, LLC | FATE THERAPEUTICS INC | 6,171,000 | 6.3% | EDGAR |
| SC 13G/A | 2024-02-09 | Capital World Investors | FATE THERAPEUTICS INC | 0 | 0.0% | EDGAR |
| SC 13G | 2024-01-25 | Point72 Asset Management, L.P. | FATE THERAPEUTICS INC | 4,730,700 | 4.8% | EDGAR |
| SC 13G/A | 2024-01-24 | BlackRock Inc. | FATE THERAPEUTICS INC | 11,212,816 | 11.4% | EDGAR |
| SC 13G/A | 2024-01-22 | STATE STREET CORP | FATE THERAPEUTICS INC | - | 1.9% | EDGAR |
| SC 13D/A | 2023-12-28 | Redmile Group, LLC | FATE THERAPEUTICS INC | 15,049,839 | 14.9% | EDGAR |
| SC 13G/A | 2023-10-10 | STATE STREET CORP | FATE THERAPEUTICS INC | - | 2.3% | EDGAR |
| SC 13G/A | 2023-05-10 | STATE STREET CORP | FATE THERAPEUTICS INC | - | 14.2% | EDGAR |
| SC 13D/A | 2023-04-19 | Redmile Group, LLC | FATE THERAPEUTICS INC | 15,071,096 | 14.9% | EDGAR |
| SC 13G | 2023-03-22 | MILLENNIUM MANAGEMENT LLC | FATE THERAPEUTICS INC | 1,696,431 | 1.7% | EDGAR |
| SC 13G/A | 2023-03-10 | VANGUARD GROUP INC | FATE THERAPEUTICS INC | 9,936,042 | 10.1% | EDGAR |
| SC 13G | 2023-02-13 | Capital World Investors | FATE THERAPEUTICS INC | 5,591,517 | 5.8% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | FATE THERAPEUTICS INC | 7,972,551 | 8.2% | EDGAR |
| SC 13G | 2023-02-03 | STATE STREET CORP | FATE THERAPEUTICS INC | - | 6.1% | EDGAR |
| SC 13G/A | 2023-01-06 | BlackRock Inc. | FATE THERAPEUTICS INC | 9,725,895 | 10.0% | EDGAR |
| SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | FATE THERAPEUTICS INC | 7,675,787 | 8.0% | EDGAR |
| SC 13G/A | 2022-02-09 | ARK Investment Management LLC | FATE THERAPEUTICS INC | 10,312,167 | 10.8% | EDGAR |
| SC 13G/A | 2022-02-03 | BlackRock Inc. | FATE THERAPEUTICS INC | 7,060,552 | 7.4% | EDGAR |